In-patient cardiac rehabilitation versus medical care – a prospective multicentre controlled 12 months follow-up in patients with coronary heart disease
Restricted accessResearch articleFirst published online August, 2011
In-patient cardiac rehabilitation versus medical care – a prospective multicentre controlled 12 months follow-up in patients with coronary heart disease
Background: The aim of this study was to evaluate a 3-week inpatient cardiac rehabilitation (Rehab) started early after the index event in patients with coronary heart disease and evidence-based secondary preventive medication.
Method: All patients had acute coronary angiography, 679 were discharged from hospital receiving usual care (Hosp), 795 completed a comprehensive Rehab. Follow-up was 12 months.
Results: Rehab patients were older (64 vs. 62 years; p < 0.001), had more multivessel disease (51 vs. 37%; p < 0.001), heart failure (64 vs. 40%, p < 0.001), ST-segment elevation myocardial infarction (59 vs. 52%, p = 0.014), and renal insufficiency (10 vs. 7%, p = 0.036). Gender, peripheral artery disease, diabetes, hypertension, and socioeconomic status were similar in groups. Rehab patients had more beta-blockers (88 vs. 75%, p < 0.001) and angiotensin-converting enzyme inhibitors (81 vs. 70%, p < 0.001), a lower low-density lipoprotein cholesterol (102 vs. 122 mg/dl, p < 0.001), and a higher proportion of non-smokers (44 vs. 39%, p = 0.024). Primary combined endpoint of mortality, myocardial infarction (MI), revascularization, and hospitalization occurred in 32.6% of Rehab patients and in 38.7% of Hosp patients [p = 0.014; absolute risk reduction 0.0615, relative risk reduction 16%, number needed to treat (NNT) 17]. Myocardial infarction (MI) (1.8 vs. 3.8%, p = 0.015; NNT 49) and hospitalization (31.8 vs. 38.0%, p = 0.013; NNT 17) were reduced. In multivariate analysis, primary endpoint was reduced significantly (OR 0.729; 95% CI 0.585–0.909; p = 0.005) giving a relative risk reduction of 27% in favour of Rehab.
Conclusion: Although Rehab patients were sicker at entry, their outcome was substantially improved within 12 months. With very low NNT, Rehab is highly effective and should be advised to all suitable patients with coronary heart disease.
WengerN. Current status of cardiac rehabilitation. J Am Coll Cardiol2008; 51(17): 1619–1631.
2.
PiepoliMCorraUBenzerWBjarnason-WehrensBDendalePGaitaD. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. Eur J Cardiovasc Prev Rehabil2010; 17(1): 1–17.
3.
OldridgeNGuyattGFischerMRimmA. Cardiac rehabilitation after myocardial infarction. Combined experience of randomised clinical trials. JAMA1988; 260(7): 945–950.
4.
O’ConnorGBuringJYusufSGoldhaberSOlmsteadEPaffenbergerR. An overview of randomised trials of rehabilitation with exercise after myocardial infarction. Circulation1989; 8(2): 234–244.
5.
Jolliffe J, Rees K, Taylor R, Thompson D, Oldridge N and Ebrahim S. Exercise-based rehabilitation for coronary heart disease (Cochrane Review). In: The Cochrane Library. Chichester, UK: John Wiley & Sons, 2003, issue 4.
6.
TaylorRBrownAEbrahimSJolliffeJNooraniHReesK. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomised controlled trials. Am J Med2004; 116(10): 682–692.
7.
ClarkAHartlingLVandermeerBMcAlisterF. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med2005; 143(9): 659–672.
8.
AntmanEAnbeDArmstrongPBatesEGreenLHandM. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. Circulation2004; 110(9): e82–292.
9.
BassandJHammCArdissinoDBoersmaEBudajAFernandez-AvilesF. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J2007; 28(13): 1598–1660.
10.
KatalinicAWaldmannASchwaabBRichardtGSheikhzadehARaspeH. The TeleGuard trial of additional telemedicine care in CAD-patients. J Telemed Telecare2008; 14(1): 17–21.
11.
Bjarnason-WehrensBHeldKHobergEKaroffMRauchB. Guidelines for the rehabilitation of patients with cardiovascular diseases. Clin Res Cardiol2007; Suppl 2: 111/1–111/54.
12.
DietzRRauchB. Guidelines for the diagnosis and treatment of chronic coronary heart disease. Z Kardiol2003; 92: 501–521.
13.
AltmanDMachinDBryantTGardnerM. Statistics with confidence: confidence intervals and statistical guidelines2003; 2nd edition. London: BMJ.
14.
Jolliffe J, Rees K, Taylor R, Thompson D, Oldridge N and Ebrahim S. Exercise based rehabilitation for coronary heart disease (Cochrane Review). In: The Cochrane Library. Chichester, UK: John Wiley & Sons. Ltd, 2009, issue 1.
15.
RasmussenJChongAAlterD. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA2007; 297(2): 177–186.
16.
SetoguchiSGlynnRAvornJMittlemanMLevinRWinkelmayerW. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge. J Am Coll Cardiol2008; 51(13): 1247–1254.
17.
MackMPrinceSHerbertMBrownPKatzMPalmerG. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting. Ann Thorac Surg2008; 86(2): 496–503.
18.
SerruysPUngerFSousaEJateneABonnierHSchönbergerJ. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med2001; 344(115): 1117–1124.
19.
SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet2002; 360(9338): 965–970.
20.
YangZShenWZhangRKongYZhangJHuJ. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease. J Interv Cardiol2007; 20(1): 10–16.
21.
HannanEWuCWalfordGCullifordAGoldJSmithC. Drug-eluting vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med2008; 358(4): 331–341.
22.
RodriguezABernardiVNaviaJBaldiJGrinfeldLMartinezJ. Argentine randomized study: Coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease. J Am Coll Cardiol2001; 37(1): 51–58.
23.
MozaffarianDWilsonPKannelW. Beyond established and novel risk factors. Lifestyle risk factors for cardiovascular disease. Circulation2008; 117(23): 3031–3038.
BenzerWPlatterMOldridgeNSchwannHMachreichKKullichW. Short-term patient-reported outcomes after different exercise-based cardiac rehabilitation programmes. Eur J Cardiovasc Prev Rehabil2007; 14(3): 441–447.
26.
ArrigoIBrunner-LaRoccaHLefkovitsMPfistererMHoffmannA. Comparative outcome one year after formal cardiac rehabilitation: the effects of a randomized intervention to improve exercise adherence. Eur J Cardiovasc Prev Rehabil2008; 15(3): 306–311.
27.
GiannuzziPTemporelliLMarchioliRMaggioniABalestroniGCeciV. Global secondary prevention strategies to limit event recurrence after myocardial infarction. Arch Intern Med2008; 168(20): 2194–2204.
28.
CortesOArthurH. Determinants of referral to cardiac rehabilitation programs in patients with coronary artery disease: A systematic review. Am Heart J2006; 151(2): 249–256.
